Meet the Team

Dean Barnes

Programme Director

Manufacturing Growth Programme

Dean has been responsible in recruiting the field team and guiding through rapid mobilisation of the Manufacturing Growth Programme (MGP) whilst leading and managing the overall delivery of both National and regional teams, while ensuring MGP achieve their overall complex contract targets in a manner that is fully ERDF compliant. Focusing on reputation, quality of clients engaged and customer satisfaction is critical to our success. Working with the Managing Director to deliver the annual MGP financial plan, which includes regular reviews, reporting on revenue, costs and expenditure, driven by monthly activity, impact and performance reports. Dean has been helping businesses to grow for a number of years, in support of growth delivered to over 6,000 SME’s from securing funding for innovative high-tech companies to personally coaching high growth businesses. Assisting those high performing businesses with the potential to grow, supporting them to achieve their ambitions whilst keeping abreast of all modern manufacturing nuances are a must. Away from work Dean is very much a football and cricket fan, time relaxing is spent reading a good Tom Sharpe novel, a motivating autobiography or watching a good thriller on T.V.

Tap into our insights

Oxford Innovation Advice offers Insights into SME needs and policy effectiveness for policy makers, funders and business support commissioners. It draws on our 30 years’ experience of delivering positive economic growth by enabling scale-ups to achieve their full potential. Each edition concludes with an ‘Implications for funders and Policy makers’ section.

Oxford Innovation Logo

Covid-19 Statement

Update – Wednesday 15th December 2021

Our Innovation Centres remain operational and accessible, and provide a safe environment for our staff and customers. We continue to assess the risk of COVID-19 alongside the latest guidance from government. In the meantime our Innovation Centre remains COVID-19 Secure and fully open for business. Our detailed risk assessment can be found here.